These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 9646059)
1. Beneficial hemodynamic effects of nicorandil in a canine model of acute congestive heart failure: comparison with nitroglycerin and cromakalim. Noguchi K; Matsuzaki T; Ojiri Y; Koyama T; Nakasone J; Sakanashi M Fundam Clin Pharmacol; 1998; 12(3):270-8. PubMed ID: 9646059 [TBL] [Abstract][Full Text] [Related]
2. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin. Kamijo T; Kamei K; Sugo I; Kamiyama T; Sudo H; Ohba Y J Cardiovasc Pharmacol; 1999 Jan; 33(1):93-101. PubMed ID: 9890402 [TBL] [Abstract][Full Text] [Related]
3. The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. Kamijo T; Tomaru T; Miwa AY; Nakamura F; Kido H; Sugimoto T; Uchida Y Jpn J Pharmacol; 1994 Jul; 65(3):223-31. PubMed ID: 7799523 [TBL] [Abstract][Full Text] [Related]
4. Comparison of development of tolerance between nicorandil and nitroglycerin in anesthetized, open-chest dogs. Kuromaru O; Sakai K Jpn J Pharmacol; 1986 Oct; 42(2):199-208. PubMed ID: 2948042 [TBL] [Abstract][Full Text] [Related]
5. Nitrate tolerance: comparison of nicorandil, isosorbide dinitrate, and nitroglycerin in anesthetized dogs. Sakai K; Kuromaru O J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S17-24. PubMed ID: 2447420 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic tolerance and pharmacokinetics of nicorandil in experimental heart failure. Bachert EL; Fung HL J Cardiovasc Pharmacol; 1993 May; 21(5):781-5. PubMed ID: 7685449 [TBL] [Abstract][Full Text] [Related]
7. Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure. Tsutamoto T; Kinoshita M; Hisanaga T; Maeda Y; Maeda K; Wada A; Fukai D; Yoshida S Am J Cardiol; 1995 Jun; 75(16):1162-5. PubMed ID: 7762505 [TBL] [Abstract][Full Text] [Related]
8. Comparative effects of nicorandil, nitroglycerin, nicotinic acid, and SG-86 on the metabolic status and functional recovery of the ischemic-reperfused myocardium. Gross GJ; Pieper GM; Warltier DC J Cardiovasc Pharmacol; 1987; 10 Suppl 8():S76-84. PubMed ID: 2447429 [TBL] [Abstract][Full Text] [Related]
9. Vasodilating effects of nicorandil and nitroglycerin in anaesthetized open-chest dogs. Sakanashi M; Noguchi K; Kato T; Sunagawa R; Ito H; Nakasone J Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):439-44. PubMed ID: 2945993 [TBL] [Abstract][Full Text] [Related]
10. Comparative effects of nicorandil and nitroglycerin on tracheal and vascular smooth muscle in the dog, in vivo and in vitro. Nakamura Y; Shiraki Y; Nabata H; Sakai K Jpn J Pharmacol; 1984 Mar; 34(3):269-76. PubMed ID: 6233439 [TBL] [Abstract][Full Text] [Related]
11. Nicorandil improves postischemic contractile function independently of direct myocardial effects. Grover GJ; Sleph PG; Parham CS J Cardiovasc Pharmacol; 1990 May; 15(5):698-705. PubMed ID: 1692928 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin. Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827 [TBL] [Abstract][Full Text] [Related]
13. Effect of KRN2391 on venous return: comparison with other vasodilators. Kaneta S; Jinno Y; Miwa A; Fukushima H; Ogawa N J Cardiovasc Pharmacol; 1993 Jul; 22(1):82-8. PubMed ID: 7690101 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the acute hemodynamic and coronary vasodilating effects between nicorandil and glyceryl trinitrate. Chibana T; Nagamine F; Sunagawa R; Oshiro K; Nakada Y; Shimabukuro M; Shinzato T; Murakami K; Mimura G; Sakanashi M Arzneimittelforschung; 1991 Jun; 41(6):591-4. PubMed ID: 1834065 [TBL] [Abstract][Full Text] [Related]
16. Hemodynamic actions of nicorandil, a new antianginal agent, in the conscious dog. Preuss KC; Gross GJ; Brooks HL; Warltier DC J Cardiovasc Pharmacol; 1985; 7(4):709-14. PubMed ID: 2410712 [TBL] [Abstract][Full Text] [Related]
17. Spasmolytic action of nicorandil in canine conductive coronary arteries in vivo is not modified by glibenclamide. Imagawa J; Akima M; Nabata H; Taira N J Cardiovasc Pharmacol; 1992 Jan; 19(1):108-14. PubMed ID: 1375676 [TBL] [Abstract][Full Text] [Related]
19. [Effects of alpha-human atrial natriuretic polypeptide (alpha-hANP) on congestive heart failure in dogs]. Sonoki H; Uchida Y; Masuo M; Tomaru T; Katoh A; Sugimoto T Nihon Yakurigaku Zasshi; 1987 Jan; 89(1):47-53. PubMed ID: 2952569 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure. Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]